...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients
【24h】

NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients

机译:NDRG1 / Cap43在肺癌患者肿瘤组织和血清中的过度表达

获取原文
获取原文并翻译 | 示例

摘要

Purpose The N-myc downstream regulated gene 1 (NDRG1)/Cap43 is overexpressed in multiple cancer types, including lung cancer. In this study, we investigated the expression of NDRG1/Cap43 in lung cancer tissues and in serum from 90 lung cancer patients and 60 healthy controls. Materials and methods Ninety patients with pathologically confirmed primary lung cancer who underwent surgical resections were recruited for the study. From resected sections, we dissected lung tumor tissues and adjacent noncancerous tissues that were used as controls and collected patient sera for NDRG1/Cap43 expression levels. Immunohistochemical staining was applied to detect NDRG1/Cap43-positive tumor cells, and real-time quantitative-PCR (RT-PCR) was used to determine mRNA transcript levels of NDRG1/Cap43 in lung cancer tissues. Serum levels of NDRG1/Cap43 were measured by Enzyme-linked immunosorbent assays (ELISA). Data comparison between two groups was performed by independent two sample test, and comparison between more than two groups was applied by the analysis of variance (ANOVA) test. Results Compared with adjacent normal tissues, lung cancer tissues had significantly increased expression of NDRG1/Cap43 (P < 0.05). Lung adenocarcinomas also had significantly higher NDRG1/Cap43 levels than lung squamous carcinomas (P < 0.01). RT-PCR analysis showed significantly higher levels of NDRG1/Cap43 mRNA transcripts in lung cancer tissues compared with matched adjacent noncancerous tissues (P < 0.05). mRNA expression of NDRG1/Cap43 was associated with the his-tological pattern of lung cancer. ELISA analysis for serum NDRG1/Cap43 levels revealed significantly higher levels in lung cancer patients (358.56 ± 233.82 ng/mL) compared with healthy controls (28.83 ± 10.51 ng/mL, P < 0.001). Conclusions NDRG1/Cap43 overexpression may be of predictive value in determining the prognosis of lung cancer patients.
机译:目的N-myc下游调控基因1(NDRG1)/ Cap43在多种类型的癌症(包括肺癌)中过表达。在这项研究中,我们调查了NDRG1 / Cap43在90例肺癌患者和60例健康对照者的肺癌组织和血清中的表达。材料和方法招募了90例经病理切除证实为原发性肺癌的患者,并进行了手术切除。从切除的切片中,我们解剖了用作对照的肺肿瘤组织和相邻的非癌组织,并收集了NDRG1 / Cap43表达水平的患者血清。免疫组织化学染色检测NDRG1 / Cap43阳性肿瘤细胞,实时定量PCR(RT-PCR)检测肺癌组织NDRG1 / Cap43的mRNA转录水平。血清NDRG1 / Cap43水平通过酶联免疫吸附测定(ELISA)进行测量。两组之间的数据比较通过独立的两个样本检验进行,两组以上的比较通过方差分析(ANOVA)检验进行。结果与癌旁正常组织相比,肺癌组织中NDRG1 / Cap43的表达显着增加(P <0.05)。肺腺癌的NDRG1 / Cap43水平也明显高于肺鳞癌(P <0.01)。 RT-PCR分析显示,与匹配的相邻非癌组织相比,肺癌组织中NDRG1 / Cap43 mRNA转录水平显着更高(P <0.05)。 NDRG1 / Cap43的mRNA表达与肺癌的组织学模式有关。血清NDRG1 / Cap43水平的ELISA分析显示,肺癌患者的水平(358.56±233.82 ng / mL)比健康对照组(28.83±10.51 ng / mL,P <0.001)高得多。结论NDRG1 / Cap43的过表达可能对判断肺癌患者的预后具有预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号